urinary%20incontinence
URINARY INCONTINENCE
Urinary incontinence is the complaint of involuntary urine leakage.
Stress urinary incontinence is the involuntary urine leakage on effort or exertion or when coughing or sneezing.
Urge urinary incontinence is the one associated with or immediately preceded by urgency.
Mixed urinary incontinence is the involuntary urine leakage associated with both urgency and with exertion, effort, coughing or sneezing.

Monitoring

Consider immediate referral to a specialist in the following conditions:

  • Incontinence w/ abdominal &/or pelvic pain
  • Hematuria in the absence of an infection
  • Suspected fistula
  • Complex neurological conditions (eg Parkinson’s disease, spinal cord injury)
  • Abnormal findings (eg pelvic mass or symptomatic organ prolapse beyond the hymen)

Consider elective referral to a specialist in the following conditions:

  • Persistent symptoms after an adequate therapeutic trial
  • Uncertain diagnosis & lack of reasonable treatment plan
  • Significant increase in PVRV that does not resolve after treatment of possible precipitants (eg medications, stool impaction)
  • Prior pelvic surgery or pelvic irradiation
  • Desire for surgical treatment
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
09 Jan 2020
Acute ischaemic stroke patients who are current or recent smokers are at greater odds of having unfavourable functional outcomes 3 months after the index event, a study has found.
Stephen Padilla, 3 days ago
Brodalumab has exhibited long-term efficacy and consistent safety profile for more than 2 years in the treatment of patients with psoriasis, results of the phase III AMAGINE-2 trial show.